Dementia-competent workforce, career advancement keys to improving Alzheimer’s care: Senate committee
By
Kimberly Bonvissuto
May 21, 2021
Developing a dementia-competent workforce and providing career advancement opportunities will help strengthen direct care workforce recruitment and retention, leading to a better quality of life for people...
Clinton shares Alzheimer’s plans
By
Lois A. Bowers
Dec 22, 2015
Democratic presidential candidate Hillary Clinton unveiled a plan Dec. 22 to invest $2 billion per year to prevent, treat and make possible a cure for Alzheimer’s disease by the year 2025 if she...
‘Alzheimer’s crisis’ intersecting with direct care workforce challenges, association says
By
Kimberly Bonvissuto
Mar 16, 2023
The nation is facing an “Alzheimer’s crisis” as the number of older adults in whom the disease is diagnosed continues to increase amid a shortage of direct care workers, according to the Alzheimer’s...
Promising Alzheimer’s drug results hailed as ‘major milestone’
By
Kimberly Bonvissuto
Sep 29, 2022
An investigational drug showing promise in reducing cognitive decline in early Alzheimer’s disease is being hailed as having potential to “change the course” of the disease.
51 percent of tweets about dementia contain stigma: study
By
Lois A. Bowers
Apr 13, 2017
Fifty-one percent of tweets by private users of Twitter accounts contain comments that are stigmatizing when they mention dementia or the people who have it, according to a recently published study.
Argentum calls for continued industry self-regulation as association ramps up advocacy efforts
By
Kimberly Bonvissuto
Sep 14, 2021
PHOENIX—Argentum has spent the past 18 months elevating several priorities, with senior living industry advocacy rising to the top as a critical need during the pandemic amid changing federal and state...
Is Alzheimer’s research about to go down a new path?
By
John O'Connor
May 07, 2019
By finding ways to prevent connection losses, the disease progression potentially could be delayed or even reversed, experts said.
Company can’t market cannabidiol products for Parkinson’s, Alzheimer’s, FDA and FTC say
By
Lois A. Bowers
Oct 23, 2019
A Florida company must stop marketing its unapproved cannabidiol products using unsubstantiated claims that the products treat Parkinson’s disease, Alzheimer’s disease and other conditions, the Food...
Recommendations to reduce disparities in dementia care due in 2021
By
Kimberly Bonvissuto
Dec 09, 2020
Final recommendations on ways to reduce disparities in dementia, which were developed during a stakeholder roundtable sponsored by the Milken Institute Alliance to Improve Dementia Care, will be released...
Dementia testing: Older adults see value, but few have undergone it
By
Kimberly Bonvissuto
Jul 24, 2023
The majority of older adults see benefit in dementia screening tests, but most have not been tested in the past year, and a majority never have been screened, according to the results of a new poll.